转移性肿瘤抗原1剪接变异体的表达与乙型肝炎病毒相关肝细胞癌早期复发及侵袭性特征相关
本研究回顾性收集102例接受根治性切除的HBV相关肝细胞癌患者,用RT-qPCR检测肿瘤及配对非肿瘤肝组织中总MTA1与MTA1dE4的表达水平。中位随访4年,24.5%患者早期复发、54.5%晚期复发;肿瘤MTA1dE4过表达与早期复发相关(P=0.0365),在AFP<200 ng/mL亚组中高MTA1dE4有助于预测早期复发(P=0.0195),体外实验显示MTA1dE4促进肝癌细胞迁移和侵袭的能力高于全长MTA1。
要点
- 肿瘤MTA1dE4过表达与HBV-HCC早期复发相关(P=0.0365),总MTA1无此关联。
- 多变量分析中仅AFP≥200 ng/mL(P=0.006)和大肿瘤体积(P=0.027)与早期复发相关。
- AFP<200 ng/mL亚组中,高MTA1dE4表达有助于预测早期复发(P=0.0195)。
核心结论
- MTA1dE4表达与更具侵袭性的肿瘤特征相关,可能作为HBV-HCC早期复发更敏感的标记物,尤其对低AFP患者。
研究设计与样本
- 回顾性收集102例接受根治性切除的HBV-HCC患者,用RT-qPCR检测配对非肿瘤与肿瘤肝组织中总MTA1/MTA1dE4表达水平。
主要发现
- 中位随访4年期间,25例(24.5%)出现早期复发(切除后12个月内),42例(54.5%)出现晚期复发。
- Kaplan-Meier分析中,肿瘤MTA1dE4过表达与早期复发相关(P=0.0365),总MTA1过表达与早期复发无关,两者均与晚期复发无关。
- 多变量分析中,仅AFP≥200 ng/mL(P=0.006)和大肿瘤体积(P=0.027)与早期复发相关。
- 在AFP<200 ng/mL亚组中,高MTA1dE4表达而非总MTA1表达有助于预测早期复发(P=0.0195)。
- 体外划痕愈合和侵袭实验显示,MTA1dE4促进肝癌细胞迁移和侵袭的能力高于全长MTA1。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Overexpression of metastatic tumor antigen 1 (MTA1) was correlated with poor prognosis of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HBV-HCC). The aim of this study was to examine the clinical significance of the expression of MTA1 and its exon 4-excluded form (MTA1dE4), the most abundant spliced variant of MTA1, in patients receiving curative resection for HBV-HCC. We collected 102 patients with HBV-HCC and received curative resection retrospectively and examined the expressions level of total MTA1/MTA1dE4 in their paired nontumor and tumor liver tissues by using RT-qPCR. The association between MTA1/MTA1dE4 expression and various tumor features as well as tumor recurrence was analyzed. During the median follow-up period of 4 years, 25 patients (24.5%) showed early recurrence (within 12 months postresection) and 42 (54.5%) showed late recurrence. In Kaplan-Meier analysis, MTA1dE4 overexpression in tumor, but not MTA1, was associated with early recurrence (P = 0.0365), but not late recurrence. In multivariate analysis, only alpha-fetoprotein (AFP) ≥200 ng/mL (P = 0.006) and large tumor size (P = 0.027) were correlated with early recurrence. In the subgroup of patients with AFP <200 ng/mL, high MTA1dE4, but not total MTA1, expression could help predict early recurrence (P = 0.0195). In vitro, wound healing and invasion assays were performed in HCC cells, and MTA1dE4 was found to exhibit a higher ability in promoting migration and invasion of hepatoma cells than full-length MTA1. Conclusion: MTA1dE4 expression is correlated with more aggressive tumor characteristics and might serve as a more sensitive marker for early recurrence of HBV-HCC, especially for low-AFP patients.
引用
- Li YT, Wu HL, Kao JH, et al. Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Hepatology. 2019. PMID: 30802976. doi:10.1002/hep.30581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。